Herbalife (NYSE:HLF - Get Free Report) will be releasing its earnings data after the market closes on Wednesday, October 30th. Analysts expect Herbalife to post earnings of $0.19 per share for the quarter. Herbalife has set its FY 2024 guidance at EPS and its Q3 2024 guidance at EPS.Parties that are interested in participating in the company's conference call can do so using this link.
Herbalife (NYSE:HLF - Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.11. Herbalife had a negative return on equity of 18.69% and a net margin of 1.63%. The firm had revenue of $1.28 billion during the quarter, compared to analysts' expectations of $1.33 billion. During the same period last year, the business posted $0.74 earnings per share. The company's revenue for the quarter was down 2.5% compared to the same quarter last year. On average, analysts expect Herbalife to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Shares of NYSE:HLF opened at $6.81 on Wednesday. Herbalife has a twelve month low of $6.59 and a twelve month high of $15.66. The company has a market cap of $680.78 million, a PE ratio of 4.97, a price-to-earnings-growth ratio of 0.27 and a beta of 1.19. The company's 50 day moving average is $7.51 and its 200 day moving average is $9.37.
In related news, Director Juan Miguel Mendoza purchased 10,000 shares of Herbalife stock in a transaction that occurred on Monday, September 9th. The stock was purchased at an average price of $7.11 per share, for a total transaction of $71,100.00. Following the transaction, the director now directly owns 120,000 shares in the company, valued at approximately $853,200. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 0.94% of the stock is owned by insiders.
A number of analysts have recently weighed in on HLF shares. DA Davidson raised their target price on shares of Herbalife from $9.50 to $13.00 and gave the stock a "neutral" rating in a report on Thursday, August 1st. StockNews.com lowered Herbalife from a "buy" rating to a "hold" rating in a research note on Tuesday. Finally, B. Riley upped their target price on Herbalife from $16.00 to $17.00 and gave the stock a "buy" rating in a research note on Thursday, August 1st. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $12.40.
View Our Latest Report on Herbalife
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.